02Sep/13

Novartis heart failure drug effective across patient groups – Reuters India

Novartis heart failure drug effective across patient groups
Reuters India
AMSTERDAM (Reuters) – An experimental drug from Novartis to treat heart failure proved equally effective regardless of the age of patients or whether they had other medical problems, clinical trial results presented on Monday showed. The drug
Novartis heart failure drug found to be effective across patient groupsGlobal Times
Novartis’ serelaxin (RLX030) improved symptoms and mortality across multiple ITNews
Novartis: RLX030 Improved Symptoms, Mortality In Heart PatientsNASDAQ

all 10 news articles »

02Sep/13

Novartis heart failure drug effective across patient groups – Reuters UK

Novartis heart failure drug effective across patient groups
Reuters UK
AMSTERDAM (Reuters) – An experimental drug from Novartis to treat heart failure proved equally effective regardless of the age of patients or whether they had other medical problems, clinical trial results presented on Monday showed. The drug
Novartis’ serelaxin (RLX030) improved symptoms and mortality across multiple ITNews
Novartis: RLX030 Improved Symptoms, Mortality In Heart PatientsNASDAQ
Novartis: RLX030 Found Effective Across Multiple Subgroups Of Heart PatientsRTT News

all 6 news articles »

02Sep/13

Novartis heart failure drug effective across patient groups – Reuters


Business Recorder

Novartis heart failure drug effective across patient groups
Reuters
Serelaxin works across sub-groups, study results show. * Heart failure drug viewed as potential blockbuster. By Ben Hirschler. AMSTERDAM, Sept 2 (Reuters) – An experimental drug from Novartis to treat heart failure proved equally effective regardless
More data backs Novartis’ serelaxin in heart failurePMLiVE

all 10 news articles »